SKYE logo

Skye Bioscience (SKYE) Net Income

Annual Net Income

-$37.64 M
-$18.16 M-93.23%

December 1, 2023


Summary


Performance

SKYE Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKYEprofitabilitymetrics:

Quarterly Net Income

-$3.90 M
+$4.00 M+50.67%

September 1, 2024


Summary


Performance

SKYE Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKYEprofitabilitymetrics:

TTM Net Income

-$21.24 M
+$21.05 M+49.77%

September 1, 2024


Summary


Performance

SKYE TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSKYEprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SKYE Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-93.2%+22.3%+43.4%
3 y3 years-473.8%-24.6%-75.5%
5 y5 years-96.1%-24.6%-75.5%

SKYE Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-341.7%at low-55.1%+84.4%-149.2%+50.7%
5 y5-year-3679.1%at low-180.3%+84.4%-257.5%+50.7%
alltimeall time-3679.1%at low-124.5%+84.4%-257.5%+50.7%

Skye Bioscience Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.90 M(-50.7%)
-$21.24 M(-49.8%)
Jun 2024
-
-$7.90 M(+57.4%)
-$42.29 M(+12.8%)
Mar 2024
-
-$5.02 M(+13.6%)
-$37.50 M(-0.4%)
Dec 2023
-$37.64 M(+93.2%)
-$4.42 M(-82.3%)
-$37.64 M(-12.7%)
Sep 2023
-
-$24.95 M(+701.7%)
-$43.12 M(+102.4%)
Jun 2023
-
-$3.11 M(-39.8%)
-$21.30 M(-1.4%)
Mar 2023
-
-$5.17 M(-47.8%)
-$21.61 M(+10.9%)
Dec 2022
-$19.48 M(+128.6%)
-$9.89 M(+216.3%)
-$19.48 M(+61.0%)
Sep 2022
-
-$3.13 M(-8.5%)
-$12.10 M(+12.1%)
Jun 2022
-
-$3.42 M(+12.4%)
-$10.80 M(+14.8%)
Mar 2022
-
-$3.04 M(+21.1%)
-$9.40 M(+10.4%)
Dec 2021
-$8.52 M(+29.9%)
-$2.51 M(+37.7%)
-$8.52 M(+13.5%)
Sep 2021
-
-$1.82 M(-9.8%)
-$7.51 M(+7.6%)
Jun 2021
-
-$2.02 M(-6.3%)
-$6.98 M(+9.5%)
Mar 2021
-
-$2.16 M(+43.8%)
-$6.38 M(-2.8%)
Dec 2020
-$6.56 M(-723.8%)
-$1.50 M(+15.8%)
-$6.56 M(+3077.1%)
Sep 2020
-
-$1.30 M(-8.7%)
-$206.50 K(-94.6%)
Jun 2020
-
-$1.42 M(-39.4%)
-$3.84 M(-128.5%)
Mar 2020
-
-$2.34 M(-148.3%)
$13.48 M(+1181.9%)
Dec 2019
$1.05 M(-105.5%)
$4.85 M(-198.4%)
$1.05 M(-110.5%)
Sep 2019
-
-$4.93 M(-131.0%)
-$10.02 M(+39.4%)
Jun 2019
-
$15.91 M(-207.7%)
-$7.19 M(-72.1%)
Mar 2019
-
-$14.77 M(+137.5%)
-$25.75 M(+34.2%)
Dec 2018
-$19.19 M
-$6.22 M(+196.8%)
-$19.19 M(+41.1%)
Sep 2018
-
-$2.10 M(-21.3%)
-$13.60 M(+13.5%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$2.66 M(-67.6%)
-$11.98 M(+19.5%)
Mar 2018
-
-$8.21 M(+1207.5%)
-$10.02 M(+224.0%)
Dec 2017
-$3.09 M(-2.6%)
-$628.20 K(+30.8%)
-$3.09 M(-13.7%)
Sep 2017
-
-$480.10 K(-31.7%)
-$3.59 M(-11.5%)
Jun 2017
-
-$702.80 K(-45.2%)
-$4.05 M(+46.0%)
Mar 2017
-
-$1.28 M(+14.5%)
-$2.78 M(-12.7%)
Dec 2016
-$3.18 M(-34.4%)
-$1.12 M(+18.5%)
-$3.18 M(+15.6%)
Sep 2016
-
-$945.30 K(-264.9%)
-$2.75 M(-8.0%)
Jun 2016
-
$573.10 K(-134.0%)
-$2.99 M(-46.8%)
Mar 2016
-
-$1.69 M(+143.8%)
-$5.62 M(+16.0%)
Dec 2015
-$4.84 M(+77.1%)
-$691.20 K(-41.6%)
-$4.84 M(-17.3%)
Sep 2015
-
-$1.18 M(-42.5%)
-$5.85 M(+5.9%)
Jun 2015
-
-$2.06 M(+126.0%)
-$5.53 M(+59.6%)
Mar 2015
-
-$910.20 K(-46.5%)
-$3.46 M(+34.9%)
Dec 2014
-$2.73 M(>+9900.0%)
-$1.70 M(+98.3%)
-$2.57 M(+198.3%)
Sep 2014
-
-$858.50 K(<-9900.0%)
-$860.60 K(>+9900.0%)
Jul 2014
-
$7800.00(-157.8%)
-$7300.00(-53.8%)
Apr 2014
-
-$13.50 K(-475.0%)
-$15.80 K(+7800.0%)
Jan 2014
-
$3600.00(-169.2%)
-$200.00(-94.4%)
Oct 2013
-$3800.00(-184.4%)
-$5200.00(+642.9%)
-$3600.00(-157.1%)
Jul 2013
-
-$700.00(-133.3%)
$6300.00(-11.3%)
Apr 2013
-
$2100.00(+950.0%)
$7100.00(+54.3%)
Jan 2013
-
$200.00(-95.7%)
$4600.00(+4.5%)
Oct 2012
$4500.00
$4700.00(+4600.0%)
$4400.00(-1566.7%)
Jul 2012
-
$100.00(-125.0%)
-$300.00(-25.0%)
Apr 2012
-
-$400.00
-$400.00

FAQ

  • What is Skye Bioscience annual net profit?
  • What is the all time high annual net income for Skye Bioscience?
  • What is Skye Bioscience annual net income year-on-year change?
  • What is Skye Bioscience quarterly net profit?
  • What is the all time high quarterly net income for Skye Bioscience?
  • What is Skye Bioscience quarterly net income year-on-year change?
  • What is Skye Bioscience TTM net profit?
  • What is the all time high TTM net income for Skye Bioscience?
  • What is Skye Bioscience TTM net income year-on-year change?

What is Skye Bioscience annual net profit?

The current annual net income of SKYE is -$37.64 M

What is the all time high annual net income for Skye Bioscience?

Skye Bioscience all-time high annual net profit is $1.05 M

What is Skye Bioscience annual net income year-on-year change?

Over the past year, SKYE annual net profit has changed by -$18.16 M (-93.23%)

What is Skye Bioscience quarterly net profit?

The current quarterly net income of SKYE is -$3.90 M

What is the all time high quarterly net income for Skye Bioscience?

Skye Bioscience all-time high quarterly net profit is $15.91 M

What is Skye Bioscience quarterly net income year-on-year change?

Over the past year, SKYE quarterly net profit has changed by +$1.12 M (+22.34%)

What is Skye Bioscience TTM net profit?

The current TTM net income of SKYE is -$21.24 M

What is the all time high TTM net income for Skye Bioscience?

Skye Bioscience all-time high TTM net profit is $13.48 M

What is Skye Bioscience TTM net income year-on-year change?

Over the past year, SKYE TTM net profit has changed by +$16.26 M (+43.35%)